Table 2.
Group/Visit | N | 25th Percentile (ng/mL) | Median (ng/mL) | 75th Percentile (ng/mL) | 90th Percentile (ng/mL) | 95th Percentile (ng/mL) | 97.5th Percentile (ng/mL) | Max (ng/mL) |
---|---|---|---|---|---|---|---|---|
Testosterone | ||||||||
Month 3 | 369 | 0.0 | 0.2 | 0.4 | 0.8 | 1.2 | 1.5 | 3.4 |
Month 12 | 359 | 0.0 | 0.2 | 0.6 | 1.2 | 1.7 | 3.4 | 10.6 |
Month 18 | 331 | −0.2 | 0.0 | 0.3 | 0.7 | 1.0 | 1.4 | 3.8 |
Placebo | ||||||||
Month 3 | 372 | −0.1 | 0.0 | 0.2 | 0.5 | 0.6 | 1.1 | 5.4 |
Month 12 | 341 | −0.1 | 0.0 | 0.2 | 0.6 | 0.8 | 1.1 | 6.7 |
Month 18 | 317 | −0.1 | 0.0 | 0.2 | 0.6 | 1.1 | 2.7 | 4.1 |